UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Need for international classification of gabapentin as a controlled substance

BMJ (Online), 2018-11, p.k4978

2018

Volltextzugriff (PDF)

Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance

Risk management and healthcare policy, 2018-01, Vol.11, p.109-116

2018

Volltextzugriff (PDF)

Predictors of Gabapentin Overuse With or Without Concomitant Opioids in a Commercially Insured U.S. Population

Pharmacotherapy, 2018-04, Vol.38 (4), p.436-443

2018

Volltextzugriff (PDF)

Authors’ Reply to: Tomoyuki Kawada’s Comment on: “All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population

Drug safety, 2018-06, Vol.41 (6), p.643-644

2018

Volltextzugriff (PDF)

Real-world use of PCSK-9 inhibitors by early adopters: cardiovascular risk factors, statin co-treatment, and short-term adherence in routine clinical practice

Therapeutics and clinical risk management, 2017-01, Vol.13, p.957-965

2017

Volltextzugriff (PDF)

Cardiovascular Risk Factors and Provision of Lifestyle Counseling for Diabetes or Prediabetes With Comorbid Obesity: Analysis of Office-Based Physician Visits Made by Patients 20 Years of Age or Older

Diabetes spectrum, 2019-02, Vol.32 (1), p.53-59

2019

Volltextzugriff (PDF)

Concomitant use of opioid medications with triptans or serotonergic antidepressants in US office-based physician visits

Drug, healthcare and patient safety, 2018-01, Vol.10, p.37-43

2018

Volltextzugriff (PDF)

Provision of Lifestyle Counseling and the Prescribing of Pharmacotherapy for Hyperlipidemia Among US Ambulatory Patients: A National Assessment of Office-Based Physician Visits

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2018-02, Vol.18 (1), p.65-71

2018

Volltextzugriff (PDF)

Call for increased pharmacovigilance of gabapentin

BMJ (Online), 2017-11, p.j5456

2017

Volltextzugriff (PDF)

Diagnoses of Cardiovascular Disease or Substance Addiction/Abuse in US Adults Treated for ADHD with Stimulants or Atomoxetine: Is Use Consistent with Product Labeling?

Drugs -- real world outcomes, 2018-03, Vol.5 (1), p.69-79

2018

Volltextzugriff (PDF)

Prevalence of depression and use of antidepressant pharmacotherapy among ambulatory patients with diabetes mellitus in the United States

Current therapeutic research, 2009-12, Vol.70 (6), p.472-476

2009

Volltextzugriff (PDF)

Selegiline transdermal system: use pattern and adherence in patients with major depressive disorder

Primary care companion for CNS disorders, 2013, Vol.15 (1)

2013

Volltextzugriff (PDF)

Prevalence of depression and receipt of antidepressant pharmacotherapy among patients with Parkinson's disease: a national assessment of US office-based physician visits

Journal of parkinsonism & restless legs syndrome, 2017-01, Vol.7, p.79-84

2017

Volltextzugriff (PDF)

Trends in ADHD and stimulant use among adults: 1995-2002

Psychiatric services (Washington, D.C.), 2005-12, Vol.56 (12)

2005

Volltextzugriff (PDF)

Authors' response to Letter to the Editor, re: Sclar DA, Robison LM, Gavrun CA Skaer TL. “Hospital length of stay for children and adolescents diagnosed with depression: is primary payer an influencing factor?” General Hospital Psychiatry 2008;30(1):73–76

General hospital psychiatry, 2010-03, Vol.32 (2), p.229-230

2010

Volltextzugriff (PDF)

Comment on: "All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population"/Reply

Drug safety, 2018-06, Vol.41 (6), p.641-644

2018

Volltextzugriff (PDF)

Quantifying Gabapentin Misuse With Opiods

Primary care companion for CNS disorders, 2019-03, Vol.21 (2)

2019

Volltextzugriff (PDF)

Trend in the use of antidepressant pharmacotherapy and diagnosis of depression in the US: An assessment of office-based visits 1990 to 1998

CNS drugs, 2000-12, Vol.14 (6), p.473-481

2000

Volltextzugriff (PDF)

First-order Economizing: Organizational Adaptation and the Elimination of Waste in the U.S. Pharmaceutical Industry

Journal of managerial issues, 2005-12, Vol.17 (4), p.511-527

2005

Volltextzugriff (PDF)

Hospital Admission for Schizophrenia and Discharge Against Medical Advice in the United States

Primary care companion to the Journal of clinical psychiatry, 2010

2010

Volltextzugriff (PDF)

Trends in Prescriptions for Antidepressant Pharmacotherapy Among US Children and Adolescents Diagnosed With Depression, 1990 Through 2001: An Assessment of Accordance With Treatment Recommendations From the American Academy of Child and Adolescent Psychiatry: Mental Health Disorders

Clinical therapeutics, 2009, Vol.31 (THEM), p.1478-1487

2009

Volltextzugriff (PDF)

Pharmaceutical economics & health policy

Clinical therapeutics, 1999-02, Vol.21 (2), p.382-382

Sclar, David Alexander

1999

Volltextzugriff (PDF)

Pharmaceutical economics & health policy: Editorial comment

Clinical therapeutics, 1998-11, Vol.20 (6), p.1192-1193

Sclar, David Alexander

1998

Volltextzugriff (PDF)

Pharmaceutical economics & health policy

Clinical therapeutics, 1998, Vol.20 (4), p.762-763

Sclar, David Alexander

1998

Volltextzugriff (PDF)

Treatment of depressive illness among children and adolescents in the United States

Current therapeutic research, 2000, Vol.61 (10), p.692-705

2000

Volltextzugriff (PDF)

1 – 25 von 133

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(108)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(133)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(43)
Science & Technology
(43)
Pharmacology & Pharmacy
(30)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Pharmacology. Drug Treatments
(11)
Medicine, Research & Experimental
(10)
Research & Experimental Medicine
(10)
Health Care Sciences & Services
(8)
Psychology. Psychoanalysis. Psychiatry
(8)
Arts & Humanities
(7)
Depression
(7)
Gabapentin
(6)
Narcotics
(6)
Cardiovascular Disease
(5)
Drug Therapy
(5)
History
(5)
Jewish People
(5)
Medicine
(5)
Neuropharmacology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Need for international classification of gabapentin as a controlled substance

Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance

Predictors of Gabapentin Overuse With or Without Concomitant Opioids in a Commercially Insured U.S. Population

Authors’ Reply to: Tomoyuki Kawada’s Comment on: “All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population

Real-world use of PCSK-9 inhibitors by early adopters: cardiovascular risk factors, statin co-treatment, and short-term adherence in routine clinical practice

Cardiovascular Risk Factors and Provision of Lifestyle Counseling for Diabetes or Prediabetes With Comorbid Obesity: Analysis of Office-Based Physician Visits Made by Patients 20 Years of Age or Older

Concomitant use of opioid medications with triptans or serotonergic antidepressants in US office-based physician visits

Provision of Lifestyle Counseling and the Prescribing of Pharmacotherapy for Hyperlipidemia Among US Ambulatory Patients: A National Assessment of Office-Based Physician Visits

Call for increased pharmacovigilance of gabapentin

Diagnoses of Cardiovascular Disease or Substance Addiction/Abuse in US Adults Treated for ADHD with Stimulants or Atomoxetine: Is Use Consistent with Product Labeling?

Prevalence of depression and use of antidepressant pharmacotherapy among ambulatory patients with diabetes mellitus in the United States

Selegiline transdermal system: use pattern and adherence in patients with major depressive disorder

Prevalence of depression and receipt of antidepressant pharmacotherapy among patients with Parkinson's disease: a national assessment of US office-based physician visits

Trends in ADHD and stimulant use among adults: 1995-2002

Authors' response to Letter to the Editor, re: Sclar DA, Robison LM, Gavrun CA Skaer TL. “Hospital length of stay for children and adolescents diagnosed with depression: is primary payer an influencing factor?” General Hospital Psychiatry 2008;30(1):73–76

Comment on: "All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population"/Reply

Quantifying Gabapentin Misuse With Opiods

Trend in the use of antidepressant pharmacotherapy and diagnosis of depression in the US: An assessment of office-based visits 1990 to 1998

First-order Economizing: Organizational Adaptation and the Elimination of Waste in the U.S. Pharmaceutical Industry

Hospital Admission for Schizophrenia and Discharge Against Medical Advice in the United States

Trends in Prescriptions for Antidepressant Pharmacotherapy Among US Children and Adolescents Diagnosed With Depression, 1990 Through 2001: An Assessment of Accordance With Treatment Recommendations From the American Academy of Child and Adolescent Psychiatry: Mental Health Disorders

Pharmaceutical economics & health policy

Pharmaceutical economics & health policy: Editorial comment

Pharmaceutical economics & health policy

Treatment of depressive illness among children and adolescents in the United States

Aktive Filter

Suchergebnisse filtern